Global Chronic Disease Management Market Report and Forecast 2024-2032

Global Chronic Disease Management Market Report and Forecast 2024-2032


Global Chronic Disease Management Outlook

The global chronic disease management market size was valued at USD 6.7 billion in 2023, driven by increasing prevalence of chronic diseases across the globe. The market size is anticipated to grow at a CAGR of 14.4% during the forecast period of 2024-2032 to achieve a value of USD 22.3 billion by 2032.

Chronic Disease Management: Introduction

Chronic Disease Management involves coordinated care and strategies aimed at preventing, monitoring, and treating long-term health conditions such as diabetes, heart disease, and hypertension. It focuses on enhancing patients' quality of life through lifestyle modifications, medication adherence, and regular monitoring, often involving a multidisciplinary healthcare team. The goal is to control symptoms, prevent complications, and improve overall well-being for individuals living with chronic diseases.

Key Trends in the Global Chronic Disease Management Market

The global chronic disease management (CDM) market has witnessed transformative trends shaping the landscape of healthcare. The advent of digital health solutions, including telemedicine platforms and wearable devices, has revolutionized remote patient monitoring, enabling real-time health tracking. Data analytics and artificial intelligence play a pivotal role, offering predictive insights and personalized treatment plans.

The shift towards patient-centric care models emphasizes engagement and education, while integrated healthcare systems foster collaboration among stakeholders. Value-based care models incentivize outcomes, driving more effective chronic disease management. Additionally, advancements in precision medicine and genomics contribute to tailored treatments. Mental health considerations have gained prominence, acknowledging the interplay between chronic conditions and mental well-being.

The COVID-19 pandemic has further accelerated the adoption of digital health solutions, cementing virtual care as a critical component of modern chronic disease management practices. These trends collectively signify a dynamic and evolving landscape, focused on improving patient outcomes and overall healthcare efficacy.

Global Chronic Disease Management Market Segmentation

Market Breakup by Type
  • Solution
  • Services
Market Breakup by Solution Type
  • On-Premise Solution
  • Cloud-Based Solution
Market Breakup by Service Type
  • Educational Service
  • Implementation Service
  • Consulting Service
  • Others
Market Breakup by Disease Indication
  • Cardiovascular Diseases (CVD)
  • Diabetes
  • Chronic Obstructive Pulmonary Disorders (COPD)
  • Arthritis
  • Asthma
  • Cancer
  • Others
Market Breakup by End User
  • Healthcare Providers
  • Healthcare Payers
  • Others
Market Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Global Chronic Disease Management Market Overview

The global CDM market has been expanding due to the rising prevalence of chronic diseases, an aging population, lifestyle changes, and increasing awareness of the importance of disease prevention and management. Digital health solutions, data analytics, and a shift towards value-based care have contributed to the market's growth.

The United States has led the global chronic disease management market share as it has been at the forefront of adopting and developing advanced healthcare technologies, including digital health solutions and telemedicine. The country's robust healthcare infrastructure and integrated healthcare systems facilitate the implementation of comprehensive chronic disease management programs. Extensive research and innovation in the healthcare sector, including precision medicine and personalized healthcare, contribute to effective chronic disease management.

the Asia Pacific (APAC) region is anticipated to grow at the fastest rate with increasing adoption of digital health solutions, telemedicine, and mobile health apps to enhance accessibility and improve remote monitoring capabilities. Governments have been focusing on robust public health initiatives, including awareness campaigns, early detection programs, and preventive measures to address the rising burden of chronic diseases.

In addition, increased collaboration among healthcare stakeholders, including governments, providers, and technology companies, to create integrated and efficient chronic disease management systems is driving market growth.

Global Chronic Disease Management: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • WellSky
  • ZeOmega
  • Health Catalyst
  • Cedar Gate Technologies
  • Cognizant
  • Pegasystems Inc.
  • Epic Systems Corporation
  • Hinduja Global Solutions Ltd.
  • NXGN Management, LLC
  • MINES & Associates, Inc.
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Chronic Disease Management Market Overview
3.1 Global Chronic Disease Management Market Historical Value (2017-2023)
3.2 Global Chronic Disease Management Market Forecast Value (2024-2032)
4 Global Chronic Disease Management Market Landscape
4.1 Global Chronic Disease Management: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Chronic Disease Management: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Chronic Disease Management Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Chronic Disease Management Market Segmentation
6.1 Global Chronic Disease Management Market by Type
6.1.1 Market Overview
6.1.2 Solution
6.1.3 Services
6.2 Global Chronic Disease Management Market by Solution Type
6.2.1 Market Overview
6.2.2 On-Premise Solution
6.2.3 Cloud-Based Solution
6.3 Global Chronic Disease Management Market by Service Type
6.3.1 Market Overview
6.3.2 Educational Service
6.3.3 Implementation Service
6.3.4 Consulting Service
6.3.5 Others
6.4 Global Chronic Disease Management Market by Disease Indication
6.4.1 Market Overview
6.4.2 Cardiovascular Diseases (CVD)
6.4.3 Diabetes
6.4.4 Chronic Obstructive Pulmonary Disorders (COPD)
6.4.5 Arthritis
6.4.6 Asthma
6.4.7 Cancer
6.4.8 Others
6.5 Global Chronic Disease Management Market by End User
6.5.1 Market Overview
6.5.2 Healthcare Providers
6.5.3 Healthcare Payers
6.5.4 Others
6.6 Global Chronic Disease Management Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Chronic Disease Management Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Chronic Disease Management Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Global Chronic Disease Management Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Chronic Disease Management Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Chronic Disease Management Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 WellSky
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 ZeOmega
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Health Catalyst
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Cedar Gate Technologies
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Cognizant
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Pegasystems Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Epic Systems Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Hinduja Global Solutions Ltd.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 NXGN Management, LLC
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 MINES & Associates, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings